COMP <GO>
APVO vs PRFX // OPERATING MARGIN
Aptevo Therapeutics Inc. (NASDAQ) VS. PRF Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: APVO 0
— PRFX 3
■ METRIC PARITY
LAST: $1.36 (+4.62%) • MKT CAP: $2.5M
operating-margins
—
LAST: $0.75 (-3.86%) • MKT CAP: $2.6M
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APVO VS. PRFX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APVO | PRFX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | -30.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | PRFX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.8 | 40.1 | -11.30 | PRFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.5M | $2.6M | -$174.4K | PRFX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APVO REV | PRFX REV | APVO GROSS % | PRFX GROSS % | APVO FCF | PRFX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $17.0K | — | -50.0% | -$25.6M | -$4.0M |
| FY 2024 | $0 | $0 | — | — | -$23.8M | -$12.6M |
| FY 2023 | $0 | $0 | — | — | -$11.7M | -$6.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APVO // BETA —
PRFX // BETA —